Andrea G Ludolph

Summary

Affiliation: University of Ulm
Country: Germany

Publications

  1. pmc Atomoxetine affects transcription/translation of the NMDA receptor and the norepinephrine transporter in the rat brain--an in vivo study
    Patrick T Udvardi
    Department of Child and Adolescent Psychiatry and Psychotherapy, University of Ulm, Ulm, Germany Institute of Anatomy and Cell Biology, University of Ulm, Ulm, Germany
    Drug Des Devel Ther 7:1433-46. 2013
  2. pmc Tourette syndrome and other tic disorders in childhood, adolescence and adulthood
    Andrea G Ludolph
    Department of Child and Adolescent Psychiatry and Psychotherapy, Ulm University Hospital, Ulm, Germany
    Dtsch Arztebl Int 109:821-288. 2012
  3. ncbi Methylphenidate exerts no neurotoxic, but neuroprotective effects in vitro
    A G Ludolph
    Department of Child and Adolescent Psychiatry, University of Ulm, Ulm, Germany
    J Neural Transm 113:1927-34. 2006
  4. doi [Attention Deficit Hyperactivity Disorder (ADHD) and road traffic - special considerations for the treatment of adolescents with ADHD]
    Andrea G Ludolph
    Klinik fur Kinder und Jugendpsychiatrie und psychotherapie, Universitatsklinikum Ulm, Ulm
    Z Kinder Jugendpsychiatr Psychother 37:405-11. 2009
  5. pmc Atomoxetine acts as an NMDA receptor blocker in clinically relevant concentrations
    Andrea G Ludolph
    Department of Child and Adolescent Psychiatry, University of Ulm, Germany
    Br J Pharmacol 160:283-91. 2010
  6. doi Dose-dependent modulation of apoptotic processes by fluoxetine in maturing neuronal cells: an in vitro study
    Ulrike Schaz
    Institute of Anatomy and Cell Biology, University of Ulm, Ulm, Germany
    World J Biol Psychiatry 12:89-98. 2011
  7. doi Are amygdalar volume alterations in children with Tourette syndrome due to ADHD comorbidity?
    Andrea G Ludolph
    Department of Child and Adolescent Psychiatry, University of Ulm, Oberer Eselsberg 45, Ulm, Germany
    Dev Med Child Neurol 50:524-9. 2008
  8. doi Dopaminergic dysfunction in attention deficit hyperactivity disorder (ADHD), differences between pharmacologically treated and never treated young adults: a 3,4-dihdroxy-6-[18F]fluorophenyl-l-alanine PET study
    Andrea G Ludolph
    Department of Child and Adolescent Psychiatry, University of Ulm, Germany
    Neuroimage 41:718-27. 2008
  9. ncbi Intensified testing for attention-deficit hyperactivity disorder (ADHD) in girls should reduce depression and smoking in adult females and the prevalence of ADHD in the longterm
    Elmar H Pinkhardt
    Department of Neurology, University of Ulm, Germany
    Med Hypotheses 72:409-12. 2009
  10. ncbi Neurodevelopmental and neurodegenerative diseases - is there a pathophysiological link? Attention-deficit/hyperactivity disorder and amyotrophic lateral sclerosis as examples
    D Lule
    Department of Neurology Neurophysiology, Oberer Eselsberg 47, University of Ulm, 89081 Ulm, Germany
    Med Hypotheses 70:1133-8. 2008

Detail Information

Publications16

  1. pmc Atomoxetine affects transcription/translation of the NMDA receptor and the norepinephrine transporter in the rat brain--an in vivo study
    Patrick T Udvardi
    Department of Child and Adolescent Psychiatry and Psychotherapy, University of Ulm, Ulm, Germany Institute of Anatomy and Cell Biology, University of Ulm, Ulm, Germany
    Drug Des Devel Ther 7:1433-46. 2013
    ..These alterations might contribute to atomoxetine's clinical effects in the treatment of ADHD, a neurodevelopmental disorder in which synaptic processes and especially a dysregulated glutamatergic metabolism seem to be involved...
  2. pmc Tourette syndrome and other tic disorders in childhood, adolescence and adulthood
    Andrea G Ludolph
    Department of Child and Adolescent Psychiatry and Psychotherapy, Ulm University Hospital, Ulm, Germany
    Dtsch Arztebl Int 109:821-288. 2012
    ..It arises in about 1% of all children, with highly varying severity. Transient and usually mild tics are seen in as many as 15% of all children in elementary school. The diagnosis is often delayed by several years...
  3. ncbi Methylphenidate exerts no neurotoxic, but neuroprotective effects in vitro
    A G Ludolph
    Department of Child and Adolescent Psychiatry, University of Ulm, Ulm, Germany
    J Neural Transm 113:1927-34. 2006
    ..The neurotoxic effects of MPP(+) could be significantly reduced by co-application of MPH, an effect that is most likely explained by MPH blocking the DAT...
  4. doi [Attention Deficit Hyperactivity Disorder (ADHD) and road traffic - special considerations for the treatment of adolescents with ADHD]
    Andrea G Ludolph
    Klinik fur Kinder und Jugendpsychiatrie und psychotherapie, Universitatsklinikum Ulm, Ulm
    Z Kinder Jugendpsychiatr Psychother 37:405-11. 2009
    ..Given the high number of traffic deaths in these young age groups consulting regarding this matter should be of high priority...
  5. pmc Atomoxetine acts as an NMDA receptor blocker in clinically relevant concentrations
    Andrea G Ludolph
    Department of Child and Adolescent Psychiatry, University of Ulm, Germany
    Br J Pharmacol 160:283-91. 2010
    ..Atomoxetine, a selective noradrenaline reuptake inhibitor, is the first non-stimulant approved for the treatment of this disorder. Here we have evaluated the effects of atomoxetine on glutamate receptors in vitro...
  6. doi Dose-dependent modulation of apoptotic processes by fluoxetine in maturing neuronal cells: an in vitro study
    Ulrike Schaz
    Institute of Anatomy and Cell Biology, University of Ulm, Ulm, Germany
    World J Biol Psychiatry 12:89-98. 2011
    ..Recent studies indicate that the selective serotonin reuptake inhibitor (SSRI) fluoxetine is not solely effective by the instant inhibition of the serotonin transporter (SERT) but also by its influence on mitotic and/or apoptotic processes...
  7. doi Are amygdalar volume alterations in children with Tourette syndrome due to ADHD comorbidity?
    Andrea G Ludolph
    Department of Child and Adolescent Psychiatry, University of Ulm, Oberer Eselsberg 45, Ulm, Germany
    Dev Med Child Neurol 50:524-9. 2008
    ..Future studies should investigate if the involvement of the amygdala is due to TS or rather caused by the genetically-linked most frequent comorbidity ADHD...
  8. doi Dopaminergic dysfunction in attention deficit hyperactivity disorder (ADHD), differences between pharmacologically treated and never treated young adults: a 3,4-dihdroxy-6-[18F]fluorophenyl-l-alanine PET study
    Andrea G Ludolph
    Department of Child and Adolescent Psychiatry, University of Ulm, Germany
    Neuroimage 41:718-27. 2008
    ..MP seems to down-regulate dopamine turnover. This effect might be one component in the mechanism of action of this drug in ADHD treatment...
  9. ncbi Intensified testing for attention-deficit hyperactivity disorder (ADHD) in girls should reduce depression and smoking in adult females and the prevalence of ADHD in the longterm
    Elmar H Pinkhardt
    Department of Neurology, University of Ulm, Germany
    Med Hypotheses 72:409-12. 2009
    ....
  10. ncbi Neurodevelopmental and neurodegenerative diseases - is there a pathophysiological link? Attention-deficit/hyperactivity disorder and amyotrophic lateral sclerosis as examples
    D Lule
    Department of Neurology Neurophysiology, Oberer Eselsberg 47, University of Ulm, 89081 Ulm, Germany
    Med Hypotheses 70:1133-8. 2008
    ..Our hypothesis of a link between ADHD and ALS could also be considered as an example how research on neurodevelopmental diseases might influence the understanding and possibly the prevention and treatment of neurodegenerative diseases...
  11. ncbi Safeguarding children's rights in psychopharmacological research: ethical and legal issues
    Michael Kölch
    Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital of Ulm, Steinhövelstr 5, 89075 Ulm, Germany
    Curr Pharm Des 16:2398-406. 2010
    ..Considering the important legislative changes in pediatric research over the past decade in both the US and Western Europe, there is a need to review recent developments in this area...
  12. ncbi Nonsuicidal self-injury and its relation to personality traits in medical students
    Marc Allroggen
    Department of Child and Adolescent Psychiatry and Psychotherapy, University of Ulm, Ulm, Germany
    J Nerv Ment Dis 202:300-4. 2014
    ..Our results are in line with previous research from other countries regarding the prevalence of NSSI among students and its association with personality. ..
  13. ncbi Grey-matter abnormalities in boys with Tourette syndrome: magnetic resonance imaging study using optimised voxel-based morphometry
    Andrea G Ludolph
    Department of Child and Adolescent Psychiatry, University of Ulm, Oberer Eselsberg 45, 889081 Ulm, Germany
    Br J Psychiatry 188:484-5. 2006
    ..This unbiased analysis confirmed an association between striatal abnormalities and Tourette syndrome, and the hippocampal volume alterations indicate an involvement of temporolimbic pathways of the CSTC in the syndrome...
  14. doi Prone to excitement: adolescent females with Non-suicidal self-injury (NSSI) show altered cortical pattern to emotional and NSS-related material
    Paul L Plener
    Department of Child and Adolescent Psychiatry and Psychotherapy, University of Ulm, Ulm, Germany
    Psychiatry Res 203:146-52. 2012
    ..Behavioural data highlight proneness to excitement regarding NSSI topics. This fMRI study provides evidence for emotion-regulation deficits in the developing brain of adolescents with NSSI...
  15. pmc European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment
    Veit Roessner
    Department of Child and Adolescent Psychiatry, University of Dresden Medical School, Fetscherstrasse 74, 01307 Dresden, Germany
    Eur Child Adolesc Psychiatry 20:173-96. 2011
    ..This summary is, however, rather a status quo of a clinically helpful but merely low evidence guideline, mainly driven by expert experience and opinion, since rigorous experimental studies are scarce...
  16. doi Nondopaminergic neurotransmission in the pathophysiology of Tourette syndrome
    Patrick T Udvardi
    Department of Child and Adolescent Psychiatry, University of Ulm, Ulm, Germany Institute of Anatomy and Cell Biology, University of Ulm, Ulm, Germany
    Int Rev Neurobiol 112:95-130. 2013
    ..Effects of agonistic or antagonistic compounds on tic symptoms might also be dose dependent. Further studies will lead to a broader spectrum of psychopharmacological treatment options in TS. ..